Abstract:RNA interference mediated by small interfering RNAs (siRNA) has emerged as a powerful tool to target specific knockdown of gene expression in cell culture. siRNA is now the gold standard technique to study gene function, and expectations for the development of new target-specific drugs are high. In addition to the gene-silencing activity of siRNA, a number of recent studies have pointed to immunological effects of siRNAs, including the induction of proinflammatory cytokines and type I interferon. There is good evidence that gene silencing and immunostimulation are two independent functional characteristics of RNA oligonucleotides. Immunorecognition of RNA depends on certain molecular features such as length, double- versus single-strand configuration, sequence motifs, and nucleoside modifications such as triphosphate residues. RNA-sensing immunoreceptors include three members of the Toll-like receptor (TLR) family (TLR3, TLR7, TLR8) and cytosolic RNA-binding proteins like PKR and the helicases RIG-I and Mda5. Detection of RNA molecules occurs during viral infection and triggers antiviral innate defense mechanisms including the induction of type I interferons (IFN-α, IFN-β) and downregulation of gene expression. Type I interferon induction by synthetic siRNAs requires TLR7 and is sequence dependent, similar to the detection of CpG motifs in DNA by TLR9. Identification of the exact molecular mechanisms of immunorecognition of RNA will allow the development of methods to avoid immunostimulation of siRNA and the design of potent immunostimulatory RNA (isRNA) oligonucleotides, depending on the aim. Furthermore, the combination of both gene-silencing and immunostimulation in one RNA molecule may lead to novel drugs that use both functional activities of RNA as two edges of one sword for effective treatment of viral infection and cancer.

L1 retrotransposon-mediated stable gene silencing.

Application of short hairpin RNAs (shRNAs) to study gene function in mammalian systems

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference

Modulation of Gene Expression by Lentiviral-Mediated Delivery of Small Interfering RNA

[RNA Interference in Functional Genomics and Medical Research].

Application of RNA Interference in Mammalian Cells

shRNA Transcribed by RNA Pol II Promoter Induce RNA Interference in Mammalian Cell

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

Stable suppression of gene expression by RNAi in mammalian cells

RNA interference with small hairpin RNAs transcribed from a human U6 promoter-driven DNA vector.

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems

RNA Interference and Potential Applications

Knockdown of Human P53 Gene Expression in 293-T Cells by Retroviral Vector-Mediated Short Hairpin Rna

In vivo self-assembled small RNAs as a new generation of RNAi therapeutics

SY-9 Stimulation of Innate Immunity by Short Interfering and Micro RNAs

Gene silencing in mammalian cells by PCR-based short hairpin RNA.

The RNA interference revolution

RNAi in mice: a promising approach to decipher gene functions in vivo

Conditional RNA interference in mammalian cells via RNA transactivation

A More Efficient RNAi Inducible System for Tight Regulation of Gene Expression in Mammalian Cells and Xenograft Animals.